ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/19 | 876 | 892 | 866 | 884 | +11 | +1.3% | 651,500 |
| 2024/03/18 | 886 | 888 | 868 | 873 | -12 | -1.4% | 635,500 |
| 2024/03/15 | 872 | 888 | 871 | 885 | +6 | +0.7% | 925,800 |
| 2024/03/14 | 885 | 888 | 869 | 879 | -10 | -1.1% | 433,900 |
| 2024/03/13 | 887 | 897 | 882 | 889 | +6 | +0.7% | 560,700 |
| 2024/03/12 | 860 | 884 | 842 | 883 | +19 | +2.2% | 640,300 |
| 2024/03/11 | 869 | 876 | 856 | 864 | -13 | -1.5% | 810,100 |
| 2024/03/08 | 875 | 889 | 869 | 877 | -13 | -1.5% | 1,093,600 |
| 2024/03/07 | 900 | 900 | 885 | 890 | -5 | -0.6% | 579,100 |
| 2024/03/06 | 884 | 907 | 883 | 895 | +4 | +0.4% | 632,500 |
| 2024/03/05 | 899 | 903 | 887 | 891 | -19 | -2.1% | 773,600 |
| 2024/03/04 | 909 | 936 | 899 | 910 | +15 | +1.7% | 907,800 |
| 2024/03/01 | 900 | 909 | 890 | 895 | -5 | -0.6% | 1,093,600 |
| 2024/02/29 | 917 | 922 | 898 | 900 | -30 | -3.2% | 831,600 |
| 2024/02/28 | 938 | 964 | 930 | 930 | +3 | +0.3% | 746,900 |
| 2024/02/27 | 896 | 931 | 893 | 927 | +28 | +3.1% | 663,300 |
| 2024/02/26 | 901 | 906 | 891 | 899 | -7 | -0.8% | 1,188,300 |
| 2024/02/22 | 915 | 923 | 902 | 906 | -5 | -0.5% | 803,800 |
| 2024/02/21 | 927 | 936 | 903 | 911 | -16 | -1.7% | 1,194,300 |
| 2024/02/20 | 927 | 940 | 924 | 927 | -1 | -0.1% | 845,600 |
| 2024/02/19 | 928 | 940 | 921 | 928 | -2 | -0.2% | 631,300 |
| 2024/02/16 | 916 | 941 | 907 | 930 | +29 | +3.2% | 926,000 |
| 2024/02/15 | 955 | 958 | 894 | 901 | -32 | -3.4% | 1,605,200 |
| 2024/02/14 | 974 | 978 | 933 | 933 | -55 | -5.6% | 1,443,100 |
| 2024/02/13 | 1,002 | 1,007 | 987 | 988 | -14 | -1.4% | 703,500 |
| 2024/02/09 | 1,011 | 1,011 | 994 | 1,002 | -8 | -0.8% | 493,600 |
| 2024/02/08 | 1,003 | 1,018 | 995 | 1,010 | +10 | +1% | 529,900 |
| 2024/02/07 | 1,009 | 1,023 | 997 | 1,000 | -8 | -0.8% | 594,100 |
| 2024/02/06 | 1,045 | 1,045 | 1,006 | 1,008 | -46 | -4.4% | 1,114,100 |
| 2024/02/05 | 1,059 | 1,063 | 1,044 | 1,054 | ±0 | ±0% | 694,600 |
| 2024/02/02 | 1,058 | 1,070 | 1,052 | 1,054 | -8 | -0.8% | 525,300 |
| 2024/02/01 | 1,085 | 1,088 | 1,059 | 1,062 | -33 | -3% | 689,500 |
| 2024/01/31 | 1,050 | 1,106 | 1,049 | 1,095 | +43 | +4.1% | 1,054,900 |
| 2024/01/30 | 1,041 | 1,065 | 1,038 | 1,052 | +22 | +2.1% | 1,113,800 |
| 2024/01/29 | 1,045 | 1,056 | 1,018 | 1,030 | -75 | -6.8% | 2,294,700 |
| 2024/01/26 | 1,120 | 1,120 | 1,097 | 1,105 | -16 | -1.4% | 828,100 |
| 2024/01/25 | 1,134 | 1,136 | 1,092 | 1,121 | -27 | -2.4% | 1,028,900 |
| 2024/01/24 | 1,152 | 1,167 | 1,145 | 1,148 | -2 | -0.2% | 337,900 |
| 2024/01/23 | 1,175 | 1,188 | 1,150 | 1,150 | -11 | -0.9% | 283,800 |
| 2024/01/22 | 1,156 | 1,170 | 1,149 | 1,161 | +10 | +0.9% | 326,500 |
| 2024/01/19 | 1,165 | 1,167 | 1,148 | 1,151 | -7 | -0.6% | 290,500 |
| 2024/01/18 | 1,165 | 1,167 | 1,144 | 1,158 | -13 | -1.1% | 447,900 |
| 2024/01/17 | 1,195 | 1,213 | 1,171 | 1,171 | -35 | -2.9% | 511,000 |
| 2024/01/16 | 1,201 | 1,219 | 1,199 | 1,206 | +3 | +0.2% | 307,500 |
| 2024/01/15 | 1,216 | 1,216 | 1,191 | 1,203 | -12 | -1% | 437,800 |
| 2024/01/12 | 1,224 | 1,228 | 1,198 | 1,215 | +1 | +0.1% | 323,000 |
| 2024/01/11 | 1,208 | 1,223 | 1,198 | 1,214 | +19 | +1.6% | 359,500 |
| 2024/01/10 | 1,165 | 1,200 | 1,158 | 1,195 | +40 | +3.5% | 407,800 |
| 2024/01/09 | 1,147 | 1,167 | 1,143 | 1,155 | +13 | +1.1% | 290,800 |
| 2024/01/05 | 1,177 | 1,178 | 1,142 | 1,142 | -44 | -3.7% | 462,000 |
351～
400
件表示中 / 7022件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 95,000円 | +20.3% | - | 0.00% | 168.44倍 | 1.31倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ハートシード | 364,000円 | +246.7% | - | 0.00% | 774.47倍 | 11.02倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| あすかＨＤ | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム
